worldwiki
governmentEvidence level AIndependent
Evidence page

FDA approves remestemcel-L-rknd for steroid-refractory acute graft versus host disease in pediatric patients

U.S. Food and Drug Administration

Published Dec 18, 2024accessed Nov 12, 2026Updated Nov 12, 2026
Original source

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-remestemcel-l-rknd-steroid-refractory-acute-graft-versus-host-disease-pediatric

fda.gov

Verification

VerificationIndependent of the subject
Evidence levelA · Government / regulator
IndependentIndependent of the subject
Sourcegovernment
Link statusReachable at last check

Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy

Cited by (6)